Mithra Pharmaceuticals, a pharmaceutical company focused on women’s health, on 1 July successfully closed its IPO on Euronext Brussels, thereby raising EUR 72.3 million (without taking into account the exercise of the over-allotment option, if any).

Eubelius is proud to have acted as counsel to Mithra in respect of this successful IPO on Euronext Brussels. The Eubelius team was led by Lars Van Bever and Michael Truyen.